Semaglutide Normalizes Increased Cardiomyocyte Calcium Transients in a Rat Model of High Fat Diet-Induced Obesity
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15152 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Vasco Sequeira und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Science Universitätsklinikum, DZHI, Würzburg, Germany. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Obesity, Diet, High-Fat, Glucagon-Like Peptides. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: IZKF Würzburg, Deutsche Forschungsgemeinschaft, Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg.
Abstract (Originalsprache)
Aims
Obesity increases the risk of heart failure with preserved (HFpEF), but not reduced ejection fraction (HFrEF). The glucagon-like peptide-1 receptor agonist (GLP-1-RA) semaglutide improves outcome of patients with obesity with or without HFpEF, while GLP-1-RAs were associated with adverse outcome in patients with HFrEF. Here, we investigate the effect of in vivo treatment with semaglutide on excitation-contraction coupling in a rat model of obesity. Methods and results Rats received high-fat/high-fructose diet for 8 weeks and were then randomized to semaglutide (HFD/Sema) or vehicle (HFD/Veh) for another 8 weeks, during which they could choose between HFD and a low-fat/high-fructose diet (LFD). Control rats received either standard chow (CON), HFD or LFD only, without treatment. After 16 weeks, sarcomere shortening and cytosolic Ca2+ concentrations ([Ca2+]c) were determined in isolated cardiomyocytes. Compared with CON, HFD/Veh increased the amplitude of [Ca2+]c transients and systolic sarcomere shortening in absence or presence of β-adrenergic stimulation, which was reversed by HFD/Sema. Caffeine-induced sarcoplasmic reticulum (SR) Ca2+ release and L-type Ca2+ channel (LTCC) currents were reduced by HFD/Sema versus HFD/Veh, while SR Ca2+ ATPase activity remained unaffected. Compared with HFD, LFD increased [Ca2+]c transients and sarcomere shortening further despite similar effects on body weight.
Conclusions
While HFD increased cardiomyocyte [Ca2+]c transients and systolic sarcomere shortening, semaglutide normalized these alterations, mediated by reduced SR Ca2+ load and LTCC currents. Because increased LTCC currents were previously traced to cardiac hypertrophy, these effects may explain why GLP-1-RAs provide benefits for patients with obesity with or without HFpEF, but rather adverse outcome in HFrEF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Science Universitätsklinikum, DZHI, Würzburg, Germany.
- Department of Internal Medicine, Division of Endocrinology and Diabetes, University Hospital Würzburg, Würzburg, Germany.
Förderung
- IZKF Würzburg
- Deutsche Forschungsgemeinschaft
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
Zitieren
APA
Sequeira, V., Theisen, J., Ermer, K. J., Oertel, M., Xu, A., Weissman, D., Ecker, K., Dudek, J., Fassnacht, M., Nickel, A., Kohlhaas, M., Maack, C., & Dischinger, U. (2025). Semaglutide Normalizes Increased Cardiomyocyte Calcium Transients in a Rat Model of High Fat Diet-Induced Obesity. ESC Heart Failure. https://doi.org/10.1002/ehf2.15152
Vancouver
Sequeira V, Theisen J, Ermer KJ, Oertel M, Xu A, Weissman D, et al. Semaglutide Normalizes Increased Cardiomyocyte Calcium Transients in a Rat Model of High Fat Diet-Induced Obesity. ESC Heart Failure. 2025. doi:10.1002/ehf2.15152
BibTeX
@article{Sequeira2025,
author = {Sequeira, Vasco and Theisen, Julia and Ermer, Katharina J and Oertel, Marie and Xu, Anton and Weissman, David and Ecker, Katharina and Dudek, Jan and Fassnacht, Martin and Nickel, Alexander and Kohlhaas, Michael and Maack, Christoph and Dischinger, Ulrich},
title = {Semaglutide Normalizes Increased Cardiomyocyte Calcium Transients in a Rat Model of High Fat Diet-Induced Obesity},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15152}
}
EUVIMED